← Back to Clinical Trials
Recruiting NCT07348679

NCT07348679 Cigarette Filter Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07348679
Status Recruiting
Phase
Sponsor Rutgers, The State University of New Jersey
Condition Smoking ( Cigarette)
Study Type INTERVENTIONAL
Enrollment 252 participants
Start Date 2026-04-28
Primary Completion 2030-12-31

Trial Parameters

Condition Smoking ( Cigarette)
Sponsor Rutgers, The State University of New Jersey
Study Type INTERVENTIONAL
Phase N/A
Enrollment 252
Sex ALL
Min Age 21 Years
Max Age N/A
Start Date 2026-04-28
Completion 2030-12-31
Interventions
Charcoal filtered cigarettes with marketingCharcoal filtered cigarette without marketingNon-charcoal filtered cigarettes

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The overall purpose of this study is to determine the effects of using charcoal-filtered cigarettes on product perceptions, smoking behaviors, and biomarkers of exposure to tobacco-related toxicants. The main questions it aims to answer are: Do perceptions of cigarettes differ by their filter? Do people smoke charcoal-filtered cigarettes differently than cigarettes with conventional filters, and does this change their exposure to cigarette harms? Study participants will complete a 5-week laboratory-based, open-label, parallel-design randomized trial. After a baseline period of smoking their preferred brand, participants will smoke charcoal-filtered or non-charcoal-filtered cigarettes for 4 weeks while completing weekly sessions to assess primary outcomes. During weekly sessions, they will smoke two cigarettes in our laboratory, provide urine and carbon monoxide samples, and complete questionnaires.

Eligibility Criteria

Inclusion Criteria: * Eligible subjects will be: 1. Male and female smokers who are at least 21 years of age and self-report smoking at least 5 cigarettes per day for at least the past 6 months. 2. Smokers of primarily non-menthol cigarettes of brands other than Natural American Spirit. 3. Not currently undergoing smoking cessation treatment or trying to quit. 4. Able to communicate fluently in English (speaking, writing, and reading). 5. Capable of giving written informed consent, which includes compliance with the requirements and restrictions listed in the combined consent and HIPAA form. Exclusion Criteria: * Subjects who self-report and/or present with the following criteria will not be eligible to participate in the study: Smoking Behavior 1. Use of menthol or Natural American Spirit cigarettes as preferred/regular brand (defined as using \>20% of the time). 2. Enrollment or plans to enroll in a smoking cessation program in the next month. 3. Provide an initial Carbon Monoxide (C

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology